MENU
+Compare
SOLTF
Stock ticker: OTC
AS OF
Dec 23 closing price
Price
$5.08
Change
-$0.26 (-4.87%)
Capitalization
469.33M

SOLTF Nxera Pharma Co.,Ltd. Forecast, Technical & Fundamental Analysis

Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company... Show more

SOLTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SOLTF with price predictions
Dec 24, 2025

SOLTF's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for SOLTF moved out of overbought territory on December 02, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 instances where the indicator moved out of the overbought zone. In of the 23 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SOLTF as a result. In of 47 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for SOLTF moved below the 200-day moving average on November 20, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

The Aroon Indicator for SOLTF entered a downward trend on December 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for SOLTF just turned positive on December 09, 2025. Looking at past instances where SOLTF's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SOLTF advanced for three days, in of 12 cases, the price rose further within the following month. The odds of a continued upward trend are .

SOLTF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SOLTF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.093) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (2.273) is also within normal values, averaging (311.015).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOLTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SOLTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2-1 Kojimachi, Chiyoda-ku
Phone
+81 352103290
Employees
181
Web
http://www.sosei.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIDFX57.740.25
+0.43%
Marsico Midcap Growth Focus Instl
IJPMX13.740.03
+0.22%
VY® JPMorgan Mid Cap Value S2
ASERX118.250.24
+0.20%
American Century Select R
MSCQX11.310.02
+0.18%
Mercer US Small/Mid Cap Equity I
RCKSX22.10N/A
N/A
Rock Oak Core Growth

SOLTF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLTF has been loosely correlated with BIESF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLTF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLTF
1D Price
Change %
SOLTF100%
N/A
BIESF - SOLTF
35%
Loosely correlated
N/A
BSFAF - SOLTF
29%
Poorly correlated
N/A
SPHRF - SOLTF
23%
Poorly correlated
N/A
SLNCF - SOLTF
9%
Poorly correlated
N/A
SPHDF - SOLTF
5%
Poorly correlated
N/A
More